Time Commitment: 3 hours 15 minutes over 6 weeks
Credits Available: 3.25 AMA PRA Category 1 Credit

Multiple myeloma is the second-most-common hematologic malignancy in the United States with approximately 34,470 new cases diagnosed in the United States in 2022. Although multiple myeloma is an incurable disease, numerous active agents are available that, when used in combination, often lead to deep and durable remissions however, the majority of patients with multiple myeloma will eventually relapse. As a result, there has been a dramatic increase in the complexity of care for patients with relapsed/refractory multiple myeloma. To address these gaps and improve the practice of clinicians who treat patients with relapsed/refractory multiple myeloma, this educational intervention will facilitate exchange of information, clinical experience, and practical guidance, while establishing sustainable support networks between the multidisciplinary healthcare team.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: MD, DO, Nurse, Nurse Practitioner, Pharmacist, Physician Assistant
Target Specialties: Hematology, Hematology/Oncology, Oncology
Group Leader

Samuel Shewan

Samuel Shewan
Physician Assistant

I have practiced in BMT and Multiple Myeloma since 2016 focusing primarily on Myeloma since 2021. I work in the outpatient setting at Huntsman Cancer Hospital and love taking care of our patients from all over Utah and the surrounding states.

 

Group Co-Leader

Kelley Julian

Huntsman Cancer Institute
Clinical Pharmacist and Residency Program Director

Dr. Kelley Julian earned her Doctor of Pharmacy in 2013 from the University of Kentucky
College of Pharmacy. She went on to complete a PGY-1 Pharmacy Practice Residency at the University of
Utah Hospital and Clinics, and a PGY-2 Hematology/Oncology Pharmacy Residency back in the Bluegrass
at UK Healthcare, where she stayed on as a clinical pharmacist until 2018 when she moved back to the mountains! Currently, Dr. Julian is the residency program director and practices as a multiple myeloma pharmacy specialist at the University of Utah Huntsman Cancer Institute located in Salt Lake City, Utah.